Therapeutic nanomedicine based on dual-intelligent functionalized gold nanoparticles for cancer imaging and therapy in vivo

Biomaterials. 2013 Nov;34(34):8798-807. doi: 10.1016/j.biomaterials.2013.07.084. Epub 2013 Aug 9.

Abstract

A novel strategy to construct a therapeutic system based on functionalized AuNPs which can specifically respond to tumor microenvironment was reported. In the therapeutic system, doxorubicin was conjugated to AuNPs via thiol-Au bond by using a peptide substrate, CPLGLAGG, which can be specifically cleaved by the protease. In vivo study shows that after injection of the functionalized AuNPs to the tumor-bearing mice, the over-expressed protease of MMP-2 in tumor tissue and intracellular GSH can lead to the rapid release of the anti-tumor drug (doxorubicin) from the functionalized AuNPs to inhibit tumor growth and realize fluorescently imaging simultaneously. The functionalized AuNPs with tumor-triggered drug release property can further improve the efficacy and reduce side effects significantly.

Keywords: Cancer imaging; Dual-intelligent; Gold nanoparticle; Therapeutic nanomedicine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Doxorubicin / administration & dosage*
  • Doxorubicin / chemistry
  • Doxorubicin / pharmacology
  • Gold / chemistry*
  • HT29 Cells
  • Humans
  • Matrix Metalloproteinase 2 / genetics
  • Matrix Metalloproteinase 2 / metabolism
  • Metal Nanoparticles / chemistry*
  • Mice
  • Mice, Inbred BALB C
  • Nanomedicine / methods*
  • Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents
  • Gold
  • Doxorubicin
  • Matrix Metalloproteinase 2
  • Mmp2 protein, mouse